Entrepreneurship

Finance your Innovation – Non-dilutive funding and support for Start-ups and SMEs

By April 18, 2020 June 3rd, 2020 No Comments
Register for event
When:

09.06.2020
16:00 – 18:30

Where:

Zoom webinar (link after registration)

Category:

Entrepreneurship

Innovation is key for continuing successful business. To initiate innovation and collaboration non-dilutive funding opportunities for companies became increasingly important as a strategic source of financing and support. In this workshop, EU-funding in Horizon2020 with the new EIC Accelerator, Eurostars and support by Innosuisse will be presented. Insights into running projects from companies’ representatives will be integrated into the program as well as tabletop exhibitions of supporting organisations.

Basel Area Business & Innovation and Euresearch Basel offer this afternoon event for SMEs, start-ups and people with an entrepreneurial spirit as well as stakeholders in this field and provide a unique overview on different funding opportunities. The mission is to help entrepreneurs to find the best matching funding instrument.

Program

16:00

Welcome by the organizers

Dr. Adrian Sprenger, Manager Entrepreneurship, Basel Area Business & Innovation
Dr. Susanne Daniel, Euresearch Company Advisor NWCH

16:15

Horizon 2020 funding for companies and experiences of a project winner

Moderation: Dr. Susanne Daniel, Euresearch Company Advisor NWCH

Speakers:
“Horizon 2020 funding for companies”
Dr. Stefan Fischer, NCP SME, Euresearch Network Office, Bern

“Disruptive GPCR lead discovery platform delivering new and safer therapeutics – Insights into an Horizon 2020 funded project”
Luca Zenone, CFO / COO, InterAx Biotech, Villigen

16:45

Bottom-up funding with Eurostars and feedback from a grantee

Moderation: Dr. Adrian Sprenger, Manager Entrepreneurship, Basel Area Business & Innovation

Speakers:
“Bottom-up funding for SMEs through Eurostars”
Dr. Andreas Gut, Head Eureka Office, Bern

“How Saverna Therapeutics benefits from a running Eurostars Project”
Dr. Marjo Götte, Co-founder, Saverna Therapeutics, Allschwil

17:20

Break

17:30

Innosuisse support and insights from companies’ perspective

Moderation: Dr. Ralf Dümpelmann, Innosuisse Special Coach

Speakers:
“Overview about Innosuisse funding and support instruments”
Dominique Gruhl-Begin, Head Start-ups and Next-Generation Innovators, Innosuisse, Bern

“A partnership to advance innovation in rare disease gene therapy”
Dr. Günther Metz, Head Business Development, Santhera Pharmaceuticals, Pratteln

18:00

Q&A session

18:30

End

Participation to the event is free of charge; however, your registration by 8th June 2020 is kindly required.

Register for event

Partner

Share this event

Want to know more about this event? Get in touch.

Dr. Adrian Sprenger
Manager Entrepreneurship

Tel: +41 61 295 50 23

Email